- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Patients with HER2- stage II/III breast cancer
Total 235990 results
-
Clovis Oncology, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor Positive | Triple Negative | HER2 | HER2 Positive | MBC | ERUnited States
-
Technical University of MunichCompletedBreast Cancer | Gastric CancerGermany
-
Bavarian NordicCompletedBreast CancerUnited States
-
Iksuda Therapeutics Ltd.RecruitingBreast Cancer | Gastric Cancer | Gastroesophageal-junction CancerAustralia
-
Shanghai CP Guojian Pharmaceutical Co., Ltd.CompletedMetastatic Breast CancerChina
-
Fudan UniversityRecruitingEffect of Drug | Gastrointestinal TumorChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownHER2-positive Breast Cancer
-
RemeGen Co., Ltd.Active, not recruitingBreast Neoplasms | Breast Diseases | HER2-positive Breast Cancer | Capecitabine | HER2 Positive Breast Carcinoma | HER2-positive Advanced Breast With Liver MetastasesChina
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi SankyoRecruitingAdvanced Breast Cancer | HER2-positive Metastatic Breast Cancer | Breast Cancer Metastatic | HER2 Low Breast CarcinomaFrance
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Advanced Solid TumorsChina
-
Shengjing HospitalRecruiting
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
Hunan Cancer HospitalCompletedBreast Neoplasms | HER2-positive Breast CancerChina
-
Zhejiang Cancer HospitalCompletedBreast Cancer | HER2 | Preoperative Systemic Treatment
-
NSABP Foundation IncGenentech, Inc.; Celcuity, LLCRecruitingHER2-negative Breast CancerUnited States
-
Jungsil RoPfizer; HK inno.N CorporationCompletedBreast CancerKorea, Republic of
-
Jungsil RoCompletedBreast CancerKorea, Republic of
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | Colorectal Cancer | Solid Tumor | Glioblastome MultiformeUnited States
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdPeking UniversityCompletedHER2-positive Solid TumorsChina
-
Universitair Ziekenhuis BrusselRecruitingCarcinoma | Receptor, ErbB-2Belgium
-
SCRI Development Innovations, LLCSanofiCompleted
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMetastatic Breast CancerItaly
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingBreast Adenocarcinoma | HER2-Positive Breast CarcinomaUnited States
-
Array Biopharma, now a wholly owned subsidiary...Completed
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)Not yet recruitingMetastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IV Colon Cancer AJCC v8 | Stage IV Colorectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8United States
-
Amunix, a Sanofi CompanyMerck Sharp & Dohme LLCRecruitingLocally Advanced or Metastatic HER2-Expressing CancersAustralia, Spain, France, Portugal
-
Novartis PharmaceuticalsAvailableHR+, HER2-, Advanced Breast Cancer
-
Pierre Fabre MedicamentIqvia Pty LtdRecruitingBreast Cancer | HER2-positive Breast Cancer | Adjuvant TherapyBelgium
-
Hoffmann-La RocheRoche Pharma AGCompletedMetastatic Breast CancerItaly, Spain, Canada, United States, Belgium, France, Germany
-
QuantumLeap Healthcare CollaborativeByondis B.V.WithdrawnOvarian Cancer | Metastatic Cancer | Metastatic Breast Cancer | Bladder Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Gastroesophageal Adenocarcinoma | Ovarian Carcinoma | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoid Tumor | HER2-positive Metastatic Breast... and other conditionsUnited States
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteThe Shulas' FoundationRecruitingTriple Negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Pravin T.P KaumayaNot yet recruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastrointestinal Carcinoma | EGFR OverexpressionUnited States
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownHER2-positive Metastatic Breast CancerChina
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
Istituto Oncologico Veneto IRCCSAssociation for Translational Research in Oncology (AS.T.R.O.)CompletedEndocrine Sensitive HER2+/HR+ Breast CancerItaly
-
Michelle MeliskoTerminatedPhase1 of Neratinib+Trastuzumab, Pertuzumab, Paclitaxel in Patients With Advanced Solid Tumors/HER2+Solid TumorUnited States
-
National Cancer Institute (NCI)TerminatedRecurrent Salivary Gland Cancer | Stage IVA Salivary Gland Cancer | Stage IVB Salivary Gland Cancer | Stage IVC Salivary Gland Cancer | High-grade Salivary Gland Mucoepidermoid Carcinoma | Salivary Gland Acinic Cell Tumor | Salivary Gland Adenocarcinoma | Salivary Gland Poorly Differentiated CarcinomaUnited States
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Unresectable Breast Carcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Unresectable HER2-Negative Breast Carcinoma | Locally Advanced HER2-Negative...United States
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedRecruitingBreast Cancer | RadiotoxicityChina
-
Daiichi SankyoRecruitingBreast Cancer | Advanced Cancer | HER2-positive Breast Cancer | HER2-low Breast CancerChina
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IIIC Breast Cancer AJCC v6 | Stage IV Breast Cancer AJCC v6 and v7United States, Puerto Rico
-
City of Hope Medical CenterActive, not recruitingBreast Cancer | Stage IV Breast CancerUnited States